PPAR-GAMMA AGONIST PIOGLITAZONE INFLUENCES PORTOSYSTEMIC COLLATERAL BLOOD FLOW BUT NOT PORTAL PRESSURE

被引：0
|
作者：
Payer, Berit A. [1 ]
Reiberger, Thomas [1 ]
Fuhrmann, Valentin H. [1 ]
Schwabl, Philipp [1 ]
Horvatits, Thomas [1 ]
Hummel, Thomas [1 ]
Jaeger, Bernhard [1 ]
Mitterhauser, Markus [1 ]
Peck-Radosavljevic, Markus [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：951A / 951A
页数：1
相关论文
共 50 条
  • [31] Proteomics and DTI Tractography Analyses for Evaluation PPAR-Gamma Agonist Treatment for Cocaine Dependence
    Tannu, Nilesh S.
    Schmitz, Joy M.
    Lane, Scott D.
    Khader, Hasan M.
    Ponnada, Narayana A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 323S - 323S
  • [32] PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy
    Ziliani da Silva Buss
    Yara S. Medeiros
    Tania S. Fröde
    Inflammation, 2012, 35 : 280 - 288
  • [33] Effect of ciglitazone, a PPAR-gamma agonist, on the proliferation of human hepatoma cells in vitro.
    Nakai, K
    Wu, V
    HEPATOLOGY, 2001, 34 (04) : 499A - 499A
  • [34] PPAR-Gamma Agonist Rosiglitazone Attenuates the Inflammation Caused by Carrageenan in the Mouse Model of Pleurisy
    Buss, Ziliani da Silva
    Medeiros, Yara S.
    Froede, Tania S.
    INFLAMMATION, 2012, 35 (01) : 280 - 288
  • [35] Primary Unresponsiveness to Pioglitazone Is Not Related to PPAR-Gamma and Its Co-Activator Gene SNP Polymorphs
    Mathur, Sandeep Kumar
    Mathur, Prashant
    Punjabi, Poonam
    Gupta, Deepak Kumar
    Thanvi, Jyoti
    Mathur, Mukul
    Mohan, Krishan
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [36] The PPAR agonist pioglitazone increases plasma renin activity independently of sodium intake and blood pressure in normal subjects
    Zanchi, A
    Nussberger, J
    Maillard, M
    Burnier, M
    JOURNAL OF HYPERTENSION, 2003, 21 : S107 - S107
  • [37] Sorafenib reduces portal pressure, the splanchnic blood flow and Portosystemic shunting in a portal-hypertensive rat model
    Reiberger, Thomas
    Angermayr, Bernhard
    Schwabl, Philipp
    Rohr-Udilova, Markus
    Peck-Radosavljevic, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (15-16) : A24 - A24
  • [38] PPAR-gamma agonists treatment affected radical and cell signaling, antioxidant response and blood pressure of hypertensive rats
    Dovinova, I.
    Kvandova, M.
    Barancik, M.
    Majzunova, M.
    Gresova, L.
    Balis, P.
    Gajdosechova, L.
    Zorad, S.
    ACTA PHYSIOLOGICA, 2014, 211 : 90 - 90
  • [39] Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone
    Rodrigo N Lamounier
    Cassio N Coimbra
    Peter White
    Flavia L Costal
    Leonardo S Oliveira
    Daniel Giannella-Neto
    Klaus H Kaestner
    Maria Lúcia Corrêa-Giannella
    Diabetology & Metabolic Syndrome, 5
  • [40] PPAR-gamma agonist rosiglitazone stops the progressive dopaminergic degeneration induced by chronic MPTP in mice
    Carta, A.
    Frau, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S122 - S122
12345